Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity (Tables)

v3.25.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2025
Stockholders' Equity  
Schedule of Stock-Based Compensation Expense

​

​

​

​

​

​

​

​

​

​

Three Months Ended March 31, 

($ in thousands)

​

2025

    

2024

Fortress:

​

​

​

​

​

​

Employee and non-employee awards

​

$

2,607

​

$

2,193

Executive awards

​

 

180

​

 

224

​

​

​

​

​

​

​

Partner Companies:

​

​

​

​

​

​

Avenue

​

 

185

​

 

191

Checkpoint

​

 

1,956

​

 

709

Mustang

​

 

38

​

 

77

Journey

​

​

1,323

​

​

1,406

Other

​

 

—

​

 

57

Total stock-based compensation expense

​

$

6,289

​

$

4,857

Schedule of Stock Option Activities

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted average

​

​

​

​

​

​

​

Total

​

remaining

​

​

​

​

Weighted average

​

weighted average

​

contractual life

​

    

Number of shares

    

exercise price

    

intrinsic value

    

(years)

Options vested and expected to vest at December 31, 2024

 

558,896

​

$

2.32

​

$

186,300

 

6.02

Forfeited

​

(540,000)

​

​

1.68

​

​

—

​

—

Options vested and expected to vest at March 31, 2025

 

18,896

​

$

20.55

​

$

—

 

0.52

Options vested and exercisable at March 31, 2025

​

18,896

​

$

20.55

​

$

—

 

0.52

Schedule of Restricted Stock Awards and Restricted Stock Units

​

​

​

​

​

​

​

​

    

​

    

Weighted

​

​

​

​

average grant

​

​

Number of shares

​

price

Unvested balance at December 31, 2024

​

4,414,724

​

$

12.87

Restricted stock granted

​

1,204,360

​

​

2.03

Restricted stock vested

​

(11,331)

​

​

34.12

Restricted stock units vested

​

(77,124)

​

​

29.17

Unvested balance at March 31, 2025

​

5,530,629

​

$

10.24

Schedule of Warrant activities

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Total weighted

​

Weighted average

​

​

​

​

​

​

​

average

​

remaining

​

​

Number of

​

Weighted average

​

 intrinsic

​

contractual life

​

    

shares

    

exercise price

    

value

    

(years)

Outstanding as of December 31, 2024

 

14,406,201

​

$

2.15

​

$

2,933,774

 

4.46

Exercised

​

(10,000)

​

​

1.68

​

​

—

​

—

Outstanding as of March 31, 2025

 

14,396,201

​

$

2.16

​

$

—

 

4.22

Exercisable as of March 31, 2025

 

14,396,201

​

$

2.16

​

$

—

 

4.22